Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

[noumoe]

Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake

Pfizer has signed a $6 billion licensing agreement with 3SBio Inc to develop a drug aimed at treating certain cancers. The drug candidate is being tested for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors in China.

3SBio plans to start a Phase III trial this year, and the drug has received FDA clearance for its Investigational New Drug application.

The agreement grants Pfizer a global license, excluding China, for the drug SSGJ-707, with a potential option for commercialization rights in China.

Pfizer will manufacture the drug in North Carolina and Kansas and plans a $100 million equity investment in 3SBio.

https://www.reuters.com/business/health ... 025-05-20/